CF Pharmtech (02652) announced interim results
- RevenueRMB2.1bn
- Net profitRMB-10.5M
- Profit attributable to ownersRMB-10.5M
- Revenue YoY+2.1%
- Net profit YoY-754.1%
- Depreciation & amortisationHK$68.5M
- Capital expenditureHK$-1.5bn
- Interest-bearing debtHK$1.5bn
Source CF Pharmtech



